Logotype for Neonode Inc

Neonode (NEON) Q2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Neonode Inc

Q2 2025 earnings summary

13 Aug, 2025

Executive summary

  • Revenue declined 25.2% year-over-year to $0.6M for Q2 2025, mainly due to lower demand in legacy printer and automotive infotainment markets.

  • Net loss for Q2 2025 was $1.9M, with operating expenses rising 5.3% year-over-year to $2.7M.

  • Cash and cash equivalents stood at $13.2M as of June 30, 2025, with management expecting sufficient liquidity for at least 12 months.

  • The company operates as a single segment focused on optical sensing and machine perception solutions, with a customer base concentrated in the US, Europe, and Asia.

  • Management is focused on expanding business opportunities and advancing MultiSensing and zForce platforms to offset legacy business declines.

Financial highlights

  • Q2 2025 revenue: $0.6M (down 25.2% year-over-year); six months: $1.1M (down 31.1%).

  • Net loss: $1.9M for Q2 2025 (vs. $1.7M in Q2 2024); $3.6M for six months (vs. $3.8M in 2024).

  • Operating loss: $2.1M for Q2 2025 (vs. $1.8M in Q2 2024); $4.1M for six months (vs. $3.7M in 2024).

  • License revenues fell 34.2% year-over-year to $0.4M, offset by a 4.3% increase in non-recurring engineering revenues to $0.2M.

  • Gross margin for Q2 2025 was 99.0%, up from 97.0% in Q2 2024.

Outlook and guidance

  • Management expects current cash reserves to fund operations for at least the next 12 months.

  • Ongoing focus on expanding the customer base and supporting new product launches with zForce and MultiSensing technologies.

  • Management expects continued revenue pressure from legacy business until new customers transition from deployment to production.

  • No material impact expected from recent US tax legislation changes.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more